Literature DB >> 12359312

Relationship between the activation of cyclic AMP responsive element binding protein and ischemic tolerance in the penumbra region of rat cerebral cortex.

Takayuki Nakajima1, Sadahiro Iwabuchi, Hiroyuki Miyazaki, Yasunobu Okuma, Osamu Inanami, Mikinori Kuwabara, Yasuyuki Nomura, Koichi Kawahara.   

Abstract

Application of a brief period of ischemia, i.e. preconditioning treatment of the middle cerebral artery territory, has been known to produce ischemic tolerance, reducing cerebral infarction volume in the penumbra region after lethal ischemia. However, little is known about the molecular mechanisms responsible for preconditioning-induced ischemic tolerance. In the present study, we examined the difference in the phosphorylation pattern of cyclic AMP responsive element binding protein (CREB) after 1 h of focal cerebral ischemia between preconditioned and non-preconditioned rats by immunohistochemistry and Western blotting. The phosphorylation of CREB in the penumbra region was more rapidly enhanced in the preconditioned rats than in the non-preconditioned rats after 1 h of ischemia. The result suggested that the immediate enhancement in the phosphorylation of CREB in the penumbra region prevented the spread of infarction in the preconditioned rats.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359312     DOI: 10.1016/s0304-3940(02)00752-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  14 in total

Review 1.  Ischemic conditioning-induced endogenous brain protection: Applications pre-, per- or post-stroke.

Authors:  Yuechun Wang; Cesar Reis; Richard Applegate; Gary Stier; Robert Martin; John H Zhang
Journal:  Exp Neurol       Date:  2015-04-18       Impact factor: 5.330

Review 2.  Ischemic tolerance as an active and intrinsic neuroprotective mechanism.

Authors:  R Anne Stetler; Feng Zhang; Collin Liu; Jun Chen
Journal:  Handb Clin Neurol       Date:  2009

3.  Functional significance of the preconditioning-induced down-regulation of glutamate transporter GLT-1 in neuron/astrocyte co-cultures.

Authors:  Tatsuro Kosugi; Koichi Kawahara; Takeshi Yamada; Takayuki Nakajima; Motoki Tanaka
Journal:  Neurochem Res       Date:  2005-09       Impact factor: 3.996

4.  Ischemic preconditioning attenuates of ischemia-induced degradation of spectrin and tau: implications for ischemic tolerance.

Authors:  Takayuki Nakajima; Syoichi Ochi; Chika Oda; Maki Ishii; Kazushige Ogawa
Journal:  Neurol Sci       Date:  2010-07-02       Impact factor: 3.307

5.  The 5α-Reductase Inhibitor Finasteride Exerts Neuroprotection Against Ischemic Brain Injury in Aged Male Rats.

Authors:  Motoki Tanaka; Takunori Ogaeri; Mikhail Samsonov; Masahiro Sokabe
Journal:  Transl Stroke Res       Date:  2018-03-25       Impact factor: 6.829

6.  NR4A orphan nuclear receptors as mediators of CREB-dependent neuroprotection.

Authors:  Nikolaos Volakakis; Banafsheh Kadkhodaei; Eliza Joodmardi; Karin Wallis; Lia Panman; Jessica Silvaggi; Bruce M Spiegelman; Thomas Perlmann
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

7.  Possible involvement of extracellular ATP-P2Y purinoceptor signaling in ischemia-induced tolerance of astrocytes in culture.

Authors:  Sadahiro Iwabuchi; Koichi Kawahara
Journal:  Neurochem Res       Date:  2009-03-14       Impact factor: 3.996

Review 8.  The neuroprotective mechanism of brain ischemic preconditioning.

Authors:  Xiao-qian Liu; Rui Sheng; Zheng-hong Qin
Journal:  Acta Pharmacol Sin       Date:  2009-07-20       Impact factor: 6.150

9.  Nitric oxide produced during ischemia is toxic but crucial to preconditioning-induced ischemic tolerance of neurons in culture.

Authors:  Koichi Kawahara; Junji Yanoma; Motoki Tanaka; Takayuki Nakajima; Tatsuro Kosugi
Journal:  Neurochem Res       Date:  2004-04       Impact factor: 3.996

10.  Preconditioning neuroprotection in global cerebral ischemia involves NMDA receptor-mediated ERK-JNK3 crosstalk.

Authors:  Quan-Guang Zhang; Rui-Min Wang; Dong Han; Li-Cai Yang; Jie Li; Darrell W Brann
Journal:  Neurosci Res       Date:  2009-03       Impact factor: 3.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.